Clinical Trials Logo

Glucose Intolerance clinical trials

View clinical trials related to Glucose Intolerance.

Filter by:

NCT ID: NCT03809182 Completed - Insulin Resistance Clinical Trials

Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.

Start date: September 27, 2012
Phase: Phase 4
Study type: Interventional

This study investigated the effect of dexmedetomidine in obese patients undergoing bariatric surgery.

NCT ID: NCT03805412 Completed - Obesity Clinical Trials

Continuous Glucose Monitoring in Diabetes and Prediabetes

Start date: January 10, 2019
Phase: N/A
Study type: Interventional

Evaluate the use of brief serial real time continuous monitoring (RT-CGM) as a behavior modification tool in obese patients with prediabetes and diabetes. After receiving RT-CGM, nutrition and exercise education, participants will be able to monitor their blood sugar in real time for 2 sessions . Education on how to interpret CGM in the setting of food choices and exercise coupled with nutrition and exercise information should lead to improved weight and other nutritional and exercise changes.

NCT ID: NCT03794232 Completed - Prediabetes Clinical Trials

Effect of Inulin-type Fructose Extracted From Jerusalem Artichoke on Improving Prediabetic State of Type 2 Diabetes

Start date: May 30, 2016
Phase: N/A
Study type: Interventional

The trial was a multicenter, randomized, double-blind, placebo-controlled, parallel-controlled, exploratory clinical study.Through the intervention of soluble dietary fiber in the pre-type 2 diabetic population, the change of blood glucose spectrum before and after intervention can show the effect of this intervention on the outcome, and further elucidate the effect of soluble dietary fiber intervention on the level of insulin resistance and its effect on outcome. Helps to prevent the more scientific and effective prevention of type 2 diabetes from pre-diabetes. Subjects who met the criteria were randomly divided into the experimental group and the control group, after 24 weeks of intervention, the incidence of blood sugar reversion to normal was main observed.The main purpose of this study was to investigate the effect of soluble dietary fiber treatment regimens on the conversion rate of pre-type 2 diabetes (converted to normal blood glucose, type 2 diabetes, or stable in the stage of impaired glucose tolerance). The secondary objective was to study the improvement of insulin resistance and changes in intestinal flora after intervention.

NCT ID: NCT03764423 Completed - Clinical trials for Impaired Glucose Tolerance

Health Effects of Salmon Fishmeal in Humans

FishMeal
Start date: September 14, 2018
Phase: N/A
Study type: Interventional

Diabetes contributes significantly to the burden of disease in Norway and cardiovascular disease is the main cause of mortality. Both lean and fatty fish are shown to have beneficial health effects. In addition to omega-3 fatty acids, fish contain potential health-promoting components such as taurine, vitamin D, vitamin B12, iodine, selenium and more unspecified components such as bioactive peptides. With the expected growth in the aquaculture sector, more protein-rich by-products will become available. The overall aim of this project is to investigate the health beneficial effects of fish protein in the form of salmon fishmeal in a human intervention study with regard to metabolic risk markers. We will include subjects with impaired glucose tolerance to a randomized controlled parallel study. The subjects will receive capsules with fishmeal or placebo.

NCT ID: NCT03737422 Completed - PreDiabetes Clinical Trials

The Effects of Hesperidin and Flaxseed in Prediabetes

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

To study the effects of Hesperidin and flaxseed supplement in patients with prediabetes, 50 patients will be randomly allocated to control group or 2 capsules Hesperidin and 30 gram flaxseed for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, lipid profiles, blood pressure, blood sugar, inflammatory and anthropometric factors will be assessed and compared between groups.

NCT ID: NCT03730727 Completed - Clinical trials for Diabetes Mellitus, Type 2

Exercise-meal Timing and Postprandial Glucose Control

Start date: October 9, 2017
Phase: N/A
Study type: Interventional

Physical activity helps maintain optimal postprandial blood glucose control. However, there is a lack of clear information regarding the optimal meal-activity timing required to maximize blood glucose control. By using continuous glucose monitoring (CGM), this randomized controlled trial will determine whether implementing a bout of physical activity immediately before, or immediately after, or shortly after a meal is most optimal. This study will also independently examine the effects of three different physical activities: walking, standing, and circuit-exercises. Minimizing the changes in blood glucose following a meal not only reduces the risk of type 2 diabetes but also reduces cardiovascular-related mortality. Therefore, the data produced by this project will have very important implications for informing healthcare policy and physical activity recommendations.

NCT ID: NCT03725033 Completed - Clinical trials for Impaired Glucose Tolerance

Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

Start date: October 10, 2018
Phase: Phase 3
Study type: Interventional

Purpose of the study: - to assess the efficacy of Subetta in the treatment of impaired glucose tolerance - to assess the safety of Subetta in the treatment of impaired glucose tolerance.

NCT ID: NCT03715010 Completed - Obese Clinical Trials

Investigation of an Amino Acid Supplement on Glucose Levels in Obese Subjects

Start date: March 18, 2016
Phase: N/A
Study type: Interventional

This study aims to determine whether the use of Branched-Chain Amino Acids (BCAA's) regulate insulin and glucagon secretion, and whether the supplement has any effect on body weight and body composition. Subjects who participate in this study will receive an 8-week supply of supplement. The study supplements will be manufactured by Scientific Living, in Irvine, CA for high dose BCAA and the low dose BCAA is manufactured by Nutribiotic, Lakeport, CA. Timed blood collections will be used to measure how BCAA affect glucose metabolism/insulin sensitivity in human subjects.

NCT ID: NCT03708939 Completed - Glucose Intolerance Clinical Trials

Microbiome and Non-caloric Sweeteners in Humans

Start date: February 19, 2017
Phase: N/A
Study type: Interventional

Non-caloric sweeteners are common food supplements consumed by millions worldwide as means of combating weight gain and diabetes, by retaining sweet taste without increasing caloric intake. While they are considered safe, there is increasing debate regarding their potential role in contributing to metabolic derangements in some humans. The investigators recently demonstrated that non-caloric sweeteners consumption could induce glucose intolerance in mice and, in preliminary experiments, in distinct human subsets, by functionally altering the gut microbiome, and that the gut microbiome plays an important role in mediating differential glucose responses to identical foods. The proportion of the human population that is susceptible to glucose intolerance induced by non-caloric sweeteners, the common factors that are shared between these individuals and whether and how the microbiome promotes the metabolic derangements remain to be addressed.

NCT ID: NCT03698786 Completed - Physical Activity Clinical Trials

Exercise Effects on Appetite-regulating Hormones and Cardiovascular Risk Factors

Start date: May 24, 2017
Phase:
Study type: Observational

The aim of this study is to examine the effect of a single bout of moderate exercise, standardized breakfast and buffet meal on appetite-related hormones, type two diabetes and cardiovascular risk factors with a comparison between healthy South Asian and white European men. It is of interest to see if any factor differences occur in appetite-regulating hormones and cardiovascular disease risk factors whilst exercising. If so strategies may be used to alter regulation in diet and exercise to reduce risk cardiovascular disease as this is the number one cause of death globally.